COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)

secukinumab
$4105.5000per ML

Strength

300 mg/2mL

NDC

00078107068

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

1/7/2026

Active Ingredients

SECUKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125504

On Market Since

1/21/2015

Pharmacological Classes

Interleukin-17A Antagonist
Interleukin-17A Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.8%

1Y

+10.5%

3Y

N/A

5Y

N/A

All

+13.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.